Insight Guru Inc.
10/01/2026 | Press release | Distributed by Public on 10/01/2026 07:04
5 Green Days In A Row: 10x Genomics Stock Is Up 20%
Shares of 10x Genomics (TXG) have closed higher in each of the last 5 sessions, a cumulative gain of 19.5%. That added about $1.9 billion to the company's market value, which now stands at about $11.7 billion. The stock closed at $90.36 on Wednesday, September 30, its highest close of the past year.
How The Streak Stacks Up Against The S&P 500
Returns for TXG and the S&P 500 over the streak and the periods around it, all ending Wednesday, September 30 and including dividends:
| Return Period | TXG | S&P 500 |
|---|---|---|
| 1 Day | 0.4% | -0.2% |
| 5 Days (Current Streak) | 19.5% | -0.7% |
| 1 Month (21 Trading Days) | 44.7% | -0.3% |
| 3 Months (63 Trading Days) | 131.4% | 2.5% |
| Year To Date | 454.0% | 12.7% |
| 1 Year (252 Trading Days) | 696.8% | 16.2% |
A Stock-Specific Run, Or A Market Move?
The market explains little of this: the S&P 500 lost 0.7% over the same 5 sessions, including dividends, against 10x Genomics' +19.5%. Over the past three months the stock is up 131.4%, a window that includes the streak; over the other 58 sessions of that window it was up 93.6%.
What The Numbers Say About The Rally
On the fundamentals, revenue declined 4.3% over the last twelve months, against a median of 8.1% for S&P 500 Health Care stocks; and its operating margin is -14.9%, versus a median of 18.3%. 10x Genomics does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The numbers make the run harder to justify: shrinking revenue and an operating loss. At this price, the stock is asking a lot of the business.
If you are looking for strength with more behind it than a hot tape, our Guidance Momentum screen surfaces the names where management raised its own outlook.
One Hot Stock Is A Story. Thirty Sound Ones Are A Strategy
A streak like this earns a place on your watchlist, and it also earns a question: how much of your outcome do you want depending on one company keeping this up?
The Trefis High Quality (HQ) Portfolio answers it with breadth: roughly 30 businesses picked for consistent cash generation, strong margins, and balance-sheet strength, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Follow the story; invest in the strategy.
Insight Guru Inc. published this content on October 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2026 at 13:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]